Publication | Closed Access
The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients
316
Citations
36
References
2006
Year
HCeq doses of at least 20 mg/d in adults with hypopituitarism are associated with an unfavorable metabolic profile. CA replacement may have metabolic advantages compared with other GCs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1